ClinicalTrials.Veeva

Menu

Mechanical Ventilation- Weaning and Thoracic Impedance Tomography

F

Federico II University

Status

Unknown

Conditions

Weaning From Mechanical Ventilation

Treatments

Device: Variable PSV
Device: NAVA
Device: Automated PSV
Device: Conventional PSV

Study type

Interventional

Funder types

Other

Identifiers

NCT03018483
PSWEAN and EIT

Details and patient eligibility

About

The aim of this multicenter, randomized controlled trial is to evaluate the weaning time from mechanical ventilation comparing non-variable PSV, variable PSV, and Smart CareTM.

This study is a multicenter randomized controlled open trial comparing variable, non-variable pressure support ventilation and Smart CareTM in patients receiving mechanical ventilation for more than 24 hours who are able to be weaned.

The aim of the study is to determine the duration of weaning from mechanical ventilation for each one of the above mentioned weaning methods

Enrollment

342 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age≥18 years
  • duration of controlled mechanical ventilation≥ 24 h
  • temperature≤ 39°C
  • hemoglobin≥ 6 g/dl
  • ratio of arterial partial pressure of oxygen to inspiratory oxygen fraction - PaO2/FiO2≥150mmHg with positive end-expiratory pressure (PEEP)≤ 16 cmH2O
  • ability of the patient to breathe spontaneously
  • informed consent

Exclusion criteria

  • patient participated in another interventional trial within the last four weeks before enrollment
  • peripheral neurological disease associated with impairment of the respiratory pump
  • muscular disease associated with impairment of the respiratory pump
  • unstable thorax with paradoxical chest wall movement
  • planned surgery under general anesthesia within 72 hours
  • difficult airway or intubation
  • existing tracheotomy at ICU admission
  • expected survival<72 hours
  • home mechanical ventilation or on chronic oxygen therapy
  • suspected or confirmed pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

342 participants in 4 patient groups

Variable PSV
Experimental group
Treatment:
Device: Variable PSV
Conventional PSV
Active Comparator group
Treatment:
Device: Conventional PSV
Automated PSV
Active Comparator group
Treatment:
Device: Automated PSV
NAVA
Active Comparator group
Treatment:
Device: NAVA

Trial contacts and locations

1

Loading...

Central trial contact

Maria Vargas

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems